List of psychedelic pharmaceutical companies — BrandWiki
BrandWiki / List of psychedelic pharmaceutical companies List of psychedelic pharmaceutical companies This is a list of psychedelic pharmaceutical companies , or pharmaceutical companies that are developing psychedelic drugs and/or related drugs such as entactogens , other hallucinogens , or non-hallucinogenic variants (e.g., psychoplastogens ) for potential medical use. [1] [2] This list also includes individual drug candidates and compounds of psychedelic pharmaceutical companies. [1]
Modern AbbVie – bretisilocin (GM-2505, 5-F-MET; acquired from Gilgamesh Pharmaceuticals) Akome Biotech – AKO-001 ( DMT combination), AKO-002 ( psilocybin combination), AKO-003 ( ketamine combination), AKO-004 ( DMT combination) Alexander Shulgin Research Institute (ASRI) – ASR-2001 (2CB-5PrO), ASR-3001 (5-MeO-iPALT) Algernon NeuroScience – DMT (AP-188) Alvarius Pharmaceuticals – 5-MeO-DMT (mebufotenin) Amandala Neuro – psilocin (ELE-101) Apex Labs – psilocybin (APEX-52/90) Arcadia Medicine – non-racemic MDMA (AM-1002), AM-1004 , AM-1006 Premodern Bristol-Myers Company – (R)-Ariadne ((R)-4C-DOM, BL-3912A, Dimoxamine) Dow Chemical Company – DOM (K-61,082), DOET Merck – MDMA , mescaline Sandoz – LSD (LSD-25, lysergide, Delysid), psilocybin (CY-39, Indocybin), psilocin (CX-59), ethocybin (CEY-19), 4-HO-DET (CZ-74), others Smith, Kline & French – MDA (SKF-5, Amphedoxamine), 3-APBT (SKF-6678) Soviet Union – α-methyltryptamine (AMT, Indopan) Upjohn See also List of investigational hallucinogens and entactogens List of psychedelic chemists List of psychedelic drugs Psychedelic Alpha Atai Life Sciences (merged with Beckley Psytech) – DMT (VLS-01), (R)-MDMA (EMP-01), ibogaine (IBX-210, DMX-1002), EGX-121 , inidascamine (RL-007), EGX-A , EGX-B , arketamine (PCN-101)
AtaiBeckley (merger of Atai Life Sciences and Beckley Psytech) – 5-MeO-DMT (mebufotenin, BPL-003), DMT (VLS-01), (R)-MDMA (EMP-01)
Awakn Life Sciences (acquired by Solvonis Therapeutics ) – ketamine (AWKN-001), MDMA (midomafetamine), esketamine (AWKN-002)
Beckley Psytech (merged with Atai Life Sciences) – 5-MeO-DMT (mebufotenin, BPL-003), psilocin (ELE-01)
BetterLife Pharma – 2-bromo-LSD (BETR-001, TD-0148A)
Biomind Labs – DMT (BMND-01–03), DMT (Triptax), 5-MeO-DMT (mebufotenin, BMND-05/08), BMND007 (DMT or 5-MeO-DMT combination), mescaline (BMND-04/06/09), ibogaine
Bright Minds Biosciences – BMB-101 , BMB-105 , BMB-201 , BMB-202 , Pharm-136
CaaMTech – CT-4201 ( psilocin prodrug), TN-001 (via spinout Transneural Therapeutics), TN-002 (via spinout Transneural Therapeutics)
Ceruvia Lifesciences – psilocybin (SYNP-101), 2-bromo-LSD (NYPRG-101)
Clearmind Medicine – MEAI (CMND-100), 2-FDCK , 3-MMC
Clexio Biosciences – esketamine (CLE-100) Definium Therapeutics (Mind Medicine, MindMed) – LSD (DT120, MM120), (R)-MDMA (MM402), zolunicant (18-MC, MM110), ketanserin (neutralizer), MDMA (midomafetamine), lys-MDA Delix Therapeutics – ibogainalog , tabernanthalog (DLX-007), zalsupindole (DLX-001, AAZ-A-154), DLX-159 , DLX-2270 , DLX-0002700 , JRT
DemeRx – ibogaine (IBX-210), noribogaine (DMX-1001)
Diamond Therapeutics – psilocybin Eleusis (acquired by Beckley Psytech) – psilocybin (ELE-101, ELE-Psilo), ELE-01 (a phenethylamine), 2C-iBu (ELE-02), ketamine (ELE-Ket)
EmpathBio – (R)-MDMA (EMP-01)
Engrail Therapeutics – ENX-105 , ENX-205
Entheon Biomedical – DMT (EBRX-101)
Entropy Neurodynamics – psilocybin (TRP-8802), psilocin (TRP-8803)
Enveric Biosciences – EB-002 (EB-373; psilocin prodrug), EB-003
Equulus Therapeutics – EQL-101 (ibogaine analogue)
Filament Health – psilocybin (PEX010)
Freedom Biosciences – ketamine/temsirolimus (FREE001)
GH Research – 5-MeO-DMT (mebufotenin, GH001–003) Gilgamesh Pharmaceuticals – bretisilocin (GM-2505, 5-F-MET), blixeprodil ((R)-4-FDCK, GM-1020), GM-3009 (an oxa-iboga), GM-5022 , GM-2040 , oxa-noribogaine , 4-allyl-6-oxa-noribogainalog Helus Pharma (Cybin) – HLP003 (CYB003, deupsilocin), HLP004 (CYB004, deudimethyltryptamine), HLP005 (CYB005), 2C-T-36 (CYB210010), DMT (SPL026), SPL028 (D2-DMT)
Incannex Healthcare – psilocybin (PSX-001) Johnson & Johnson – esketamine (Spravato), ITI-1549 (via acquiring Intra-Cellular Therapies )
Journey Colab – mescaline (JOUR-5700)
Ketabon – oral prolonged-release ketamine (KET01)
Küleon Bioscience (Psilosterics) – KB-128
Lophora – LPH-5 ((S)-2C-TFM-3PIP), LPH-48
Lucid Psycheceuticals – Lucid-PSYCH (Lucid-201)
Lusaris Therapeutics – 5-MeO-DMT (mebufotenin)
MiHKAL – lys-MDA , SDA , SDMA MindBio Therapeutics – LSD (MB-22001) Mindset Pharma (acquired by Otsuka Pharmaceutical ) – MSP-1014 ( psilocin prodrug), MSP-2020 , MSP-4018 , MSP-4019 , MSP-4020
Mindstate Design Labs – 5-MeO-MiPT (MSD-001), 5-MeO-MiPT combinations (e.g., MSD-101, MSD-201, etc.)
MSICS Pharma – psilocybin (MSX-06)
Multidisciplinary Association for Psychedelic Studies (MAPS) – MDMA (midomafetamine)
MycoMedica Life Sciences – psilocybin (MLS101) Mydecine – psilocybin (MYCO-001/003), MYCO-006 , MYCO-007 , MYCO-002 , MYCO-004 , MYCO-005
Negev Labs – HBL20016 (5-MeS-6-F-DMT), HBL20017 (4-F-5-MeS-DMT)
Neurala Biosciences – DMT/harmala alkaloids (NBX-100, NBX-200)
Neurocentrx Pharma – misuse-deterrant oral ketamine (NRCx-201)
Ninnion Therapeutics – NIN-S119 (a tryptamine)
Nobilis Therapeutics – xenon (NBTX-001)
NRx Pharmaceuticals – ketamine (NRX-100)
PharmAla Biotech – non-racemic MDMA , MBDB
Pilz Bioscience – psilocin (PLZ-1015), baeocystin (PLZ-1019), norpsilocin (PLZ-1017)
Psilera – DMT , PSIL-001 , PSIL-002 , PSIL-006 , PSIL-020 , PSIL-025 , 4-AcO-DMT
PsyBio Therapeutics – psilocybin (PB-1818), norbaeocystin
Psychae Therapeutics – DMT/β-carboline
Psyence Biomedical (Psyence BioMed) – [natural] psilocybin
Reconnect Labs – dimethyltryptamine/harmine (RE01), sublingual 5-MeO-DMT (mebufotenin; RE02)
Relmada Therapeutics – psilocybin (REL-P11)
Reset Pharma – psilocybin (RSTP-1000)
Resilient Pharmaceuticals (Lykos Pharmaceuticals, MAPS Public Benefit Corporation) – MDMA (midomafetamine)
Reunion Neuroscience (Field Trip Health) – luvesilocin (RE104, FT104, 4-GO-DiPT), RE109 (FT109, 4-GO-DMT), RE245
Revive Therapeutics – psilocybin (PSY-0.1–0.6)
Scottsdale Research Institute – psilocybin-containing mushrooms
Seaport Therapeutics – SPT-348 ( 2-bromo-LSD prodrug)
Seelos Therapeutics – ketamine (Ereska, PMI-100, PMI-150, SLS-002, TUR-002)
Sensorium Therapeutics – SNTX-2643 (SENS-01; kanna derivative)
Small Pharma (acquired by Cybin/Helus Pharma) – DMT (SPL026), SPL028 (D2-DMT)
Solvonis Therapeutics – ketamine (SVN-001), esketamine (SVN-002), SVN-114 (SVN-SDN-14 series), SVN-015
Tactogen – MDMA/citalopram , TACT411 , TACT523 , TACT833 , TACT908 , 1Z2MAP1O , 1ZP2MA
Terran Biosciences – eplivanserin/volinanserin (trip killer/blocker)
Tryp Therapeutics – psilocybin (PFN, TRP-8802–8804, TRYP-0082)
Usona Institute – psilocybin , 5-MeO-DMT (me bufotenin ), bufotenin (5-HO-DMT)
Xylo (Psylo) – XYL-1001 (PSYLO-1001), XYL-1002 (PSYLO-1002), XYL-3001 (PSYLO-3001), XYL-4001 (PSYLO-4001), XYL-5001 (PSYLO-5001) –
α-ethyltryptamine
(AET, etryptamine, Monase)
